Showing 1 - 10 results of 10 for search 'Samir S. Khariwala', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
Simultaneous analysis of urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, N′-nitrosonornicotine, and cotinine by liquid chromatography-tandem mass-spectrometry by Sampada S. Nikam, Murari Gurjar, Hitesh Singhavi, Anand Patil, Arjun Singh, Peter Villalta, Pankaj Chaturvedi, Samir S. Khariwala, Vikram Gota, Irina Stepanov
Published 2021-10-01
Article -
6
Screening for HPV-Related Oropharyngeal Cancer in Gay and Bisexual Men: Acceptability and Predicting Possible Use of “Oral Selfies” by Smartphone as a Secondary Prevention Approach... by Michael W. Ross, Sarah L. Bennis, Niles Zoschke, Brian R. Simon Rosser, Cyndee L. Stull, Alan G. Nyitray, Samir S. Khariwala, Mark Nichols, Charlene Flash, Michael Wilkerson
Published 2023-12-01
Article -
7
Variability in addictive and carcinogenic potential of smokeless tobacco products marketed in Mumbai, India: a surveillance studyResearch in context by Sampada S. Nikam, Vikram Gota, Prakash C. Gupta, Namrata Puntambekar, Arjun Singh, Pankaj Chaturvedi, Peter W. Villalta, Dorothy K. Hatsukami, Jasjit S. Ahluwalia, Saonli Basu, Samir S. Khariwala, Irina Stepanov
Published 2024-10-01
Article -
8
Oral/oropharyngeal “selfies” in gay and bisexual men: a pilot study exploring oropharyngeal screening for HPV-related possible malignancies by Michael W. Ross, Sarah L. Bennis, C. Mark Nichols, I. Niles Zoschke, J. Michael Wilkerson, B. R. Simon Rosser, Cyndee L. Stull, Alan G. Nyitray, Charlene Flash, Samir S. Khariwala
Published 2023-09-01
Article -
9
HPV-related oropharyngeal cancer early detection in gay and bisexual men is an “orphan” practice: A qualitative analysis among healthcare providers by I. Niles Zoschke, Sarah L. Bennis, J. Michael Wilkerson, Cynthia L. Stull, Alan G. Nyitray, Alan G. Nyitray, Samir S. Khariwala, C. Mark Nichols, B. R. Simon Rosser, Charlene Flash, Charlene Flash, Charlene Flash, Michael W. Ross
Published 2023-04-01
Article -
10
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial by Tina J. Hieken, Garth D. Nelson, Thomas J. Flotte, Eric P. Grewal, Jun Chen, Robert R. McWilliams, Lisa A. Kottschade, Lu Yang, Evidio Domingo-Musibay, Roxana S. Dronca, Yiyi Yan, Svetomir N. Markovic, Anastasios Dimou, Heather N. Montane, Courtney L. Erskine, Mara A. Piltin, Daniel L. Price, Samir S. Khariwala, Jane Hui, Carrie A. Strand, Susan M. Harrington, Vera J. Suman, Haidong Dong, Matthew S. Block
Published 2024-02-01
Article